Drug Shortage Report for APO-IRBESARTAN
Report ID | 55810 |
Drug Identification Number | 02386984 |
Brand name | APO-IRBESARTAN |
Common or Proper name | IRBESARTAN |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 BTL |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-10-31 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-08-17 |
Shortage status | Avoided shortage |
Updated date | 2018-08-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-08-21 | French | Compare |
v5 | 2018-08-21 | English | Compare |
v4 | 2018-08-21 | French | Compare |
v3 | 2018-08-21 | English | Compare |
v2 | 2018-07-15 | French | Compare |
v1 | 2018-07-15 | English | Compare |
Showing 1 to 6 of 6